Japan Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook

The viral vector and plasmid dna manufacturing market in Japan is expected to reach a projected revenue of US$ 781.8 million by 2030. A compound annual growth rate of 20.6% is expected of Japan viral vector and plasmid dna manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$210.4
Forecast, 2030 (US$M)
$781.8
CAGR, 2024 - 2030
20.6%
Report Coverage
Japan

Japan viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)

Japan

Related Markets

Japan viral vector and plasmid dna manufacturing market highlights

  • The Japan viral vector and plasmid dna manufacturing market generated a revenue of USD 210.4 million in 2023 and is expected to reach USD 781.8 million by 2030.
  • The Japan market is expected to grow at a CAGR of 20.6% from 2024 to 2030.
  • In terms of segment, adeno-associated virus (aav) was the largest revenue generating vector type in 2023.
  • Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.


Viral vector and plasmid dna manufacturing market data book summary

Market revenue in 2023USD 210.4 million
Market revenue in 2030USD 781.8 million
Growth rate20.6% (CAGR from 2023 to 2030)
Largest segmentAdeno-associated virus (aav)
Fastest growing segmentAdeno-associated virus (AAV)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAdeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids
Key market players worldwideMerck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc


Other key industry trends

  • In terms of revenue, Japan accounted for 3.9% of the global viral vector and plasmid dna manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China viral vector and plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,175.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Vector And Plasmid DNA Manufacturing Market Companies

Name Profile # Employees HQ Website

Japan viral vector and plasmid dna manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.


Adeno-associated virus (aav) was the largest segment with a revenue share of 19.96% in 2023. Horizon Databook has segmented the Japan viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.


Japan is anticipated to account for a significant share of the Asia Pacific viral vectors and plasmid DNA manufacturing market, as it has one of the most developed pharmaceutical and biotechnology sectors in the region.

Moreover, the high prevalence of chronic diseases and rare genetic disorders has led to increase in R&D activities for the development of novel therapies and vaccines, creating high demand for DNA manufacturing solutions for research purposes.

For instance, in May 2020, Takara Bio contracted AGC Biologics to produce an intermediate COVID-19 DNA vaccine (a circular DNA [pDNA] that includes the target pathogen's protein).

Reasons to subscribe to Japan viral vector and plasmid dna manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan viral vector and plasmid dna manufacturing market databook

  • Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Japan viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)

Japan Viral Vector And Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Japan viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more